Biliary neoptenn concentrations were measured daily in nine liver-transplant recipients during the early post-transplant period (on average, 25 days). Concentrations increased stronglyduring rejectionepisodes and decreased quickly after successful antirejection therapy. Contrary to the changes of urinary neopterin, cytomegalovirus infection and hepatitis were not associated with an increase in biliary neopterin concentrations. Therefore, measurement of neopterin in bile fluid and in urine may aid in distinguishing rejection from infectious complications in liverallograft recipients. 
plant period (on average, 25 days). Concentrations increased stronglyduring rejectionepisodes and decreased quickly after successful antirejection therapy. Contrary to the changes of urinary neopterin, cytomegalovirus infection and hepatitis were not associated with an increase in biliary neopterin concentrations. Therefore, measurement of neopterin in bile fluid and in urine may aid in distinguishing rejection from infectious complications in liverallograft recipients. The kinetics of increasing neopterin (rather than an upper limit) are used as a sign for immunologic activation. Therefore, neopterin is measured daily. The increase of neopterin is an important and necessary sign complementing the other clinical and laboratory data. Neopterin increases as much as 4 days before the other indexes change.
CMV infection was diagnosed when antibodies to 1gM appeared or titers of IgG antibodies to CMV increased at least fourfold within 2 weeks. Diagnosis of CMV disease was made from a combination of CMV serology with clinical symptoms, such as unexplained fever, increase in transaminases, cytopenia, intestinal pneumonitis, and ulceration of the gastrointestinal tract. CMV serology was performed by a quantitative enzyme-linked imniunosorbent assay of IgG and 1gM antibodies as described (10) . Hepatitis B or C was diagnosed by clinical observations, determination of HBs and HBe antigens in serum, and histological evaluation of liver fine-needle biopsate.
The ratio of neopterin to creatinine in urine was determined in the first morning urine samples by reversed-phase HPLC (11, 12) . Biliary concentrations of neopterin were determined by a method previously described for assessing neopterin in serum (13) . In this such as acute rejection (n = 6) and infection with CMV (n = 2), hepatitis B (n = 1), hepatitis C (n = 1), or herpes simplex (n = 1) (Figure 1, top) . During rejection episodes, biliary neopterin concentrations also were higher (Figure 1, bottom) . The increase in bile fluid was more pronounced, and the decrease of neopterin concentration after successful antirejection therapy was more rapid than in urine. However, biliary neopterin concentrations began to increase -24 h after urinary values started to increase. The bile flow was not influenced by rejection except for one patient in whom a slight decrease was observed. In contrast to their effect on ui-inary neopterin, CMV, hepatitis B and C, and herpes simplex infections were not accompanied by increasing biliary neopterin concentrations. 
DIscussion
This is the first study measuring neopterin in bile fluid. Our results suggest that the increase in the concentration of biliary neopterin is more pronounced than that of urinary neopterin during acute rejection episodes. Interestingly, biliary neopterin did not increase significantly during CMV, herpes simplex, and viral hepatitis B and C infections. In contrast, urinary and serum neopterin increased strongly during these In rejection the increase in urinary neopterin concen- 
